PCI Biotech: First patient enrolled in the fimaChem pivotal RELEASE study


You May Also Like

UroGen to Present at March 2018 Investor Conferences

RA’ANANA, Israel and NEW YORK, March 07, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

Delcath Announces Another DSMB Recommendation for Phase 3 Focus Trial

FOCUS trial to continue without modificationNEW YORK, May 03, 2018 (GLOBE NEWSWIRE) -- Delcath ...